{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:01:39Z","timestamp":1786114899754,"version":"build-2736575974"},"reference-count":72,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Angiol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Asymptomatic peripheral artery disease (PAD), present in 50 to 70% of all PAD cases, carries substantial cardiovascular and limb-related risks, yet remains clinically underrecognized. Despite a low ankle\u2013brachial index (ABI) predicting 1.5- to 2.5-fold increased cardiovascular mortality and progressive limb disease, the translation from detection to clinical benefit remains uncertain. The 2018 U.S. Preventive Services Task Force concluded that the evidence is insufficient to support universal ABI screening in asymptomatic adults. This narrative review synthesized evidence on asymptomatic PAD screening and early diagnosis via PubMed\/MEDLINE search (inception to December 2025) and targeted review of guidelines, high-quality evidence, with priority given to randomized trials, observational cohorts, systematic reviews, and meta-analyses addressing test performance, feasibility, and linkage of detection to actionable care pathways. Asymptomatic PAD affects 8.5 million Americans and 200 million people globally, with highest prevalence in African-American populations (27\u201330% lifetime risk). Low ABI independently predicts cardiovascular mortality, major adverse events, and impaired functional capacity. Risk-stratified screening demonstrates cost-effectiveness, though medial arterial calcification limits ABI reliability in diabetes and chronic kidney disease. No large randomized trials directly demonstrate that screening-detected PAD, when coupled with structured intervention, improves clinical outcomes. Early detection of asymptomatic PAD identifies high-risk patients warranting intensive preventive therapy. Targeted screening in high-risk populations appears reasonable; however, systematic implementation requires validated protocols, clear interpretation algorithms, and proven downstream care pathways. Outcome-driven trials directly testing screening-based interventions remain essential to resolve the screening debate.<\/jats:p>","DOI":"10.1055\/a-2809-5934","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:33:44Z","timestamp":1771547624000},"page":"196-203","source":"Crossref","is-referenced-by-count":0,"title":["Screening and Early Diagnosis of Asymptomatic Peripheral Artery Disease"],"prefix":"10.1055","volume":"35","author":[{"given":"Kunal","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3906-480X","authenticated-orcid":false,"given":"Lakshmi","family":"Kattamuri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-3694","authenticated-orcid":false,"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"25","key":"ref1","first-page":"2982","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"G A Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jacc.2008.09.063","article-title":"Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study)","volume":"53","author":"M M McDermott","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"F G Fowkes","year":"2008","journal-title":"JAMA"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.2018.8357","article-title":"Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index: US Preventive Services Task Force recommendation statement","volume":"320","author":"S J Curry","year":"2018","journal-title":"JAMA"},{"issue":"08","key":"ref5","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"P Song","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"09","key":"ref6","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"S S Virani","year":"2020","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"F G Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"09","key":"ref8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"M H Criqui","year":"2015","journal-title":"Circ Res"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amepre.2006.12.010","article-title":"Ethnic-specific prevalence of peripheral arterial disease in the United States","volume":"32","author":"M A Allison","year":"2007","journal-title":"Am J Prev Med"},{"issue":"18","key":"ref10","doi-asserted-by":"crossref","first-page":"e012177","DOI":"10.1161\/JAHA.119.012177","article-title":"Lifetime risk of lower-extremity peripheral artery disease defined by ankle-brachial index in the United States","volume":"8","author":"K Matsushita","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.05.049","article-title":"Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases","volume":"74","author":"N Ding","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"ref12","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/jama.2012.13415","article-title":"Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men","volume":"308","author":"M M Joosten","year":"2012","journal-title":"JAMA"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/aje\/kwi167","article-title":"Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis","volume":"162","author":"M M McDermott","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"14","key":"ref14","first-page":"e877","article-title":"Sex differences in peripheral vascular disease: a scientific statement from the American Heart Association","volume":"151","author":"E SH Kim","year":"2025","journal-title":"Circulation"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.292.4.453","article-title":"Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms","volume":"292","author":"M M McDermott","year":"2004","journal-title":"JAMA"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jvs.2004.02.010","article-title":"Natural history of physical function in older men with intermittent claudication","volume":"40","author":"A W Gardner","year":"2004","journal-title":"J Vasc Surg"},{"issue":"19","key":"ref17","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1161\/CIRCULATIONAHA.107.736108","article-title":"Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication","volume":"117","author":"M M McDermott","year":"2008","journal-title":"Circulation"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1358863X11431106","article-title":"Progression of asymptomatic peripheral artery disease over 1 year","volume":"17","author":"E R Mohler III","year":"2012","journal-title":"Vasc Med"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"M H Criqui","year":"1992","journal-title":"N Engl J Med"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/25.6.1172","article-title":"Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population","volume":"25","author":"G C Leng","year":"1996","journal-title":"Int J Epidemiol"},{"issue":"08","key":"ref21","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.avsg.2010.06.001","article-title":"Asymptomatic peripheral arterial disease in type 2 diabetes patients: a 10-year follow-up study of the utility of the ankle brachial index as a prognostic marker of cardiovascular disease","volume":"24","author":"M Bund\u00f3","year":"2010","journal-title":"Ann Vasc Surg"},{"issue":"21","key":"ref22","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","article-title":"Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease","volume":"120","author":"C Diehm","year":"2009","journal-title":"Circulation"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/000331979504600304","article-title":"Ankle\/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality","volume":"46","author":"M Kornitzer","year":"1995","journal-title":"Angiology"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jclinepi.2003.09.003","article-title":"Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study","volume":"57","author":"J D Hooi","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"e000257","DOI":"10.1161\/JAHA.113.000257","article-title":"Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study","volume":"2","author":"M M McDermott","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"09","key":"ref26","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCRESAHA.114.303517","article-title":"Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia","volume":"116","author":"M M McDermott","year":"2015","journal-title":"Circ Res"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jvs.2007.02.004","article-title":"A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences","volume":"45","author":"B Sigvant","year":"2007","journal-title":"J Vasc Surg"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"A T Hirsch","year":"2001","journal-title":"JAMA"},{"issue":"13","key":"ref29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.286.13.1599","article-title":"Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment","volume":"286","author":"M M McDermott","year":"2001","journal-title":"JAMA"},{"issue":"07","key":"ref30","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1532-5415.2010.02941.x","article-title":"Leg symptom categories and rates of mobility decline in peripheral arterial disease","volume":"58","author":"M M McDermott","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1358863X9600100112","article-title":"The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing","volume":"1","author":"M H Criqui","year":"1996","journal-title":"Vasc Med"},{"key":"ref32","volume-title":"Cardiovascular Survey Methods [by] G. A. Rose [and] H","author":"G A Rose","year":"1968"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jama.295.5.536","article-title":"Does the clinical examination predict lower extremity peripheral arterial disease?","volume":"295","author":"N A Khan","year":"2006","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"M S Conte","year":"2015","journal-title":"J Vasc Surg"},{"issue":"24","key":"ref35","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association","volume":"126","author":"V Aboyans","year":"2012","journal-title":"Circulation"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0301-5629(96)00036-1","article-title":"ROC analysis of noninvasive tests for peripheral arterial disease","volume":"22","author":"J G Lijmer","year":"1996","journal-title":"Ultrasound Med Biol"},{"issue":"05","key":"ref37","first-page":"788","article-title":"Diagnostic utility of the two methods of ankle brachial index in the detection of peripheral arterial disease of lower extremities","volume":"68","author":"K Niazi","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-136-12-200206180-00008","article-title":"The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study","volume":"136","author":"M M McDermott","year":"2002","journal-title":"Ann Intern Med"},{"issue":"12","key":"ref39","first-page":"e726","article-title":"2016 AHA\/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"M D Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.2337\/diacare.28.9.2206","article-title":"An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes","volume":"28","author":"D T Williams","year":"2005","journal-title":"Diabetes Care"},{"issue":"05","key":"ref41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ahj.2011.02.003","article-title":"Ankle brachial index screening in asymptomatic older adults","volume":"161","author":"R E Taylor-Piliae","year":"2011","journal-title":"Am Heart J"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1358863X18781723","article-title":"Comparison of different exercise ankle pressure indices in the diagnosis of peripheral artery disease","volume":"23","author":"A W Aday","year":"2018","journal-title":"Vasc Med"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.semvascsurg.2022.04.009","article-title":"Noninvasive studies for the peripheral artery disease patient","volume":"35","author":"A Harrington","year":"2022","journal-title":"Semin Vasc Surg"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jvs.2018.04.018","article-title":"The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures","volume":"68","author":"R E Zierler","year":"2018","journal-title":"J Vasc Surg"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"M S Conte","year":"2019","journal-title":"J Vasc Surg"},{"issue":"06","key":"ref46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.107.719369","article-title":"Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk","volume":"117","author":"A D Pradhan","year":"2008","journal-title":"Circulation"},{"issue":"08","key":"ref47","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1532-5415.2008.01797.x","article-title":"Circulating blood markers and functional impairment in peripheral arterial disease","volume":"56","author":"M M McDermott","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/01.CIR.0000025636.03561.EE","article-title":"Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men","volume":"106","author":"A D Pradhan","year":"2002","journal-title":"Circulation"},{"issue":"07","key":"ref49","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.104.513085","article-title":"C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study","volume":"112","author":"I Tzoulaki","year":"2005","journal-title":"Circulation"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1191\/1358863x03vm503oa","article-title":"Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease","volume":"8","author":"A Silvestro","year":"2003","journal-title":"Vasc Med"},{"issue":"22","key":"ref51","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.3390\/cells12222647","article-title":"Cardiovascular biomarkers: current status and future directions","volume":"12","author":"M G Filipovic","year":"2023","journal-title":"Cells"},{"issue":"09","key":"ref52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"F GR Fowkes","year":"2010","journal-title":"JAMA"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"J Belch","year":"2008","journal-title":"BMJ"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0004-9514(14)60166-5","article-title":"Improving maximum walking distance in early peripheral arterial disease: randomised controlled trial","volume":"48","author":"B Fowler","year":"2002","journal-title":"Aust J Physiother"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF02879914","article-title":"Unsupervised walking therapy and atherosclerotic risk-factor management for patients with peripheral arterial disease: a pilot trial","volume":"33","author":"T C Collins","year":"2007","journal-title":"Ann Behav Med"},{"issue":"24","key":"ref56","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"H L Gornik","year":"2024","journal-title":"Circulation"},{"issue":"36","key":"ref57","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"L Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"issue":"05","key":"ref58","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mayocpiqo.2023.08.004","article-title":"Exercise therapy in the management of peripheral arterial disease","volume":"7","author":"A O Hallak","year":"2023","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"issue":"15","key":"ref59","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa2208681","article-title":"Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) trial","volume":"387","author":"J S Lindholt","year":"2022","journal-title":"N Engl J Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0140-6736(17)32250-X","article-title":"Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial","volume":"390","author":"J S Lindholt","year":"2017","journal-title":"Lancet"},{"issue":"04","key":"ref61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","author":"Heart Protection Study Collaborative Group","year":"2007","journal-title":"J Vasc Surg"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"S Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"22","key":"ref63","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.2018.5422","article-title":"Antithrombotic therapy for peripheral artery disease in 2018","volume":"319","author":"C N Hess","year":"2018","journal-title":"JAMA"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1249\/MSS.0000000000002109","article-title":"Effects of lifestyle physical activity on vascular function in asymptomatic peripheral arterial disease","volume":"52","author":"S Laslovich","year":"2020","journal-title":"Med Sci Sports Exerc"},{"issue":"12","key":"ref65","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/CIRCRESAHA.121.318243","article-title":"Racial and ethnic disparities in peripheral artery disease","volume":"128","author":"E L Hackler III","year":"2021","journal-title":"Circ Res"},{"issue":"11","key":"ref66","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/ATVBAHA.123.319399","article-title":"Sex and racial disparities in peripheral artery disease","volume":"43","author":"S Divakaran","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157016110791112304","article-title":"The importance of early diagnosis and treatment in peripheral arterial disease: insights from the PARTNERS and REACH registries","volume":"8","author":"D Mukherjee","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1570161114999160719104936","article-title":"Increased exercise favorably modifies coronary artery disease and peripheral arterial disease outcomes","volume":"14","author":"T F Whayne","year":"2016","journal-title":"Curr Vasc Pharmacol"},{"issue":"10","key":"ref69","first-page":"999","article-title":"Peripheral arterial disease: considerations in risks, diagnosis, and treatment","volume":"101","author":"D Mukherjee","year":"2009","journal-title":"J Natl Med Assoc"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0031-1278244","article-title":"Peripheral arterial disease: epidemiology, natural history, diagnosis and treatment","volume":"16","author":"G Dhaliwal","year":"2007","journal-title":"Int J Angiol"},{"issue":"08","key":"ref71","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3949\/ccjm.68.8.723","article-title":"Update on peripheral vascular diseases: from smoking cessation to stenting","volume":"68","author":"D Mukherjee","year":"2001","journal-title":"Cleve Clin J Med"},{"issue":"04","key":"ref72","doi-asserted-by":"crossref","first-page":"JC22","DOI":"10.7326\/ACPJ202008180-022","article-title":"After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleeding","volume":"173","author":"D Mukherjee","year":"2020","journal-title":"Ann Intern Med"}],"container-title":["International Journal of Angiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2809-5934.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:32:10Z","timestamp":1785969130000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2809-5934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":72,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2809-5934","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1061-1711","1615-5939"],"issn-type":[{"value":"1061-1711","type":"print"},{"value":"1615-5939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]}}}